Comparing cancer costs is challenging, despite new price transparency rules

January 16, 2020

Comparison shopping for airfare, a TV, or a car can be straightforward online. The same cannot be said for checking what hospitals charge for a standard radiation treatment for prostate cancer, according to a report published in JAMA Oncology. Trevor Royce, MD, MPH, MS, of the University of North Carolina Lineberger Comprehensive Cancer Center, is … Continued

Dittus and colleagues write the book on rare lymphomas

January 14, 2020

UNC Lineberger’s Christopher Dittus, DO, MPH, assistant professor of medicine at UNC School of Medicine, is the editor of a new book that provides a comprehensive review of how to diagnose and manage rare lymphomas, with a focus on novel treatment approaches. UNC Lineberger faculty and trainees contributed chapters to the volume. “Novel Therapeutics for … Continued

Phase I study indicates drug could boost immune function in blood cancers

January 14, 2020

An early-stage clinical study investigating a method of boosting the body’s defenses against two blood cancers found the drug pomalidomide could be safely added to conventional treatments, and help improve immune function. University of North Carolina Lineberger Comprehensive Cancer Center researcher Joshua Zeidner, MD, assistant professor in the UNC School of Medicine Division of Hematology/Oncology, … Continued

Top cancer minds use smart tools to impact patient care

January 6, 2020

UNC Lineberger’s Ethan Basch, MD, MSc, is setting out to make an impact on cancer care by using one of the best tools in his medical arsenal – cancer patients themselves. Basch, the Richard M. Goldberg Distinguished Professor in Medical Oncology and the director of the Cancer Outcomes Research Program, is highly engaged in patient-reported … Continued

Prostate Cancer Foundation awards grant to Coombs

December 17, 2019

The Prostate Cancer Foundation has awarded $225,000 across three years to UNC Lineberger’s Catherine C. Coombs, MD, to study whether genetic mutations that accumulate in the blood over time are linked to worse outcomes for prostate cancer. Coombs, an assistant professor in the UNC School of Medicine Division of Hematology/Oncology, received the Young Investigator Award … Continued

Pancreatic cancer tumor classification could optimize treatment choices

November 21, 2019

A study from the University of North Carolina Lineberger Comprehensive Cancer Center could help predict resistance to treatments for pancreatic cancer, one of the deadliest cancer types. In Clinical Cancer Research, a journal of the American Association for Cancer Research, researchers led by UNC Lineberger’s Jen Jen Yeh, MD, and Naim Rashid, PhD, reported findings … Continued

NIH awards grant to Painschab to improve multicentric Castleman disease treatment in Malawi

October 21, 2019

The National Institutes of Health Fogarty International Center has awarded Matthew Painschab, MD, a five-year International Research Scientist Development Award to lead research into improving treatment for multicentric Castleman disease in Malawi. Working through the University of North Carolina Project-Malawi, a collaboration between UNC-Chapel Hill and the Malawi Ministry of Health, Painschab will lead a … Continued

Researchers develop method for separating tissue types in tumor samples

October 21, 2019

A dense web of tissue can surround pancreatic cancer tumors, impeding treatment and sometimes acting as a barrier to the tumor’s spread. Researchers want to distinguish cancerous tissue from the surrounding connective tissue and cells known as stroma as well as from immune cells in the tumor’s environment in order to drive personalized treatment strategies. … Continued